Research and education at IGP
News
Newsletter
Recent research papers from IGP
-
1p/19q co-deletion status is associated with distinct tumor-associated macrophage infiltration in IDH mutated lower-grade gliomas
2021
-
3,4-Difluorobenzocurcumin Inhibits Vegfc-Vegfr3-Erk Signalling to Block Developmental Lymphangiogenesis in Zebrafish
2021
-
5-HT1A targeting PARCEST agent DO3AM-MPP with potential for receptor imaging: Synthesis, physico-chemical and MR studies
2021
-
A case report of a patient with metastatic uveal melanoma who experienced a complete response to treatment with the NIVO3+IPI1 regimen
2021
-
A combined approach for single-cell mRNA and intracellular protein expression analysis
2021
-
A Comprehensive Evaluation of Associations Between Routinely Collected Staging Information and The Response to (Chemo)Radiotherapy in Rectal Cancer
2021
-
A Comprehensive Evaluation of the Relationship Between Different IgG and IgA Anti-Modified Protein Autoantibodies in Rheumatoid Arthritis
2021
-
A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma
2021
-
A dual role of YAP in driving TGF beta-mediated endothelial-to-mesenchymal transition
2021
-
A human cell type similar to murine central nervous system perivascular fibroblasts
2021
Welcome to IGP
The department conducts advanced research and education in areas such as clinical immunology, medical genetics and genomics, pathology, oncology, neuro-oncology, vascular biology, molecular tools and medical radiation sciences.
Some of our activities are integrated with clinics at Uppsala University Hospital.
Find examples of research at the Department in Our research in images.
Follow us on Twitter: @IgpUu
New research findings from IGP
-
Brain tumour organisation modelled by new method
2021-09-16
Researchers at IGP have developed a new method to uncover how individual cancer cells change over time. The method offers a way to understand how the heterogeneity of brain tumours arises and could lead to an increased understanding of therapy resistance and to the development of new drug combinations. The study has been published in the journal Molecular Systems Biology.
-
Combination of technologies could be used in drug development
2021-09-03
A new combination of technologies can be used to examine how drugs interact with their targets. This is shown by IGP researchers in a paper published in the journal Analytical Chemistry. The method can be used to analyse a large number of samples, in particular for small sample sizes, and could be applied during drug development and in the clinic.
-
New prediction model for colon cancer recurrence
2021-08-31
Researchers at IGP have together with Norwegian colleagues developed a model for predicting the risk for recurrence after colon cancer surgery that is more accurate than previous models. The aim is that doctors could use the model when they discuss treatment options with their patients.